International Clinical Trial: A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients with Polypoidal Choroidal Vasculopathy (PCV)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115109) titled 'A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients with Polypoidal Choroidal Vasculopathy (PCV)' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai General Hospital

Condition: Neovascular age related macular degeneration(nAMD), Polypoidal Choroidal Vasculopathy (PCV)

Intervention: Arm A:Aflibercept Intravitreous Injection

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-01-01

Target Sample Siz...